Related Experiment Video
Updated: May 27, 2026

13:42
Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
Microfluidic device to investigate factors affecting performance in biosensors designed for transdermal applications
Jakub Trzebinski1, Sanjiv Sharma, Anna Radomska-Botelho Moniz
1Institute of Biomedical Engineering & Department of Chemistry, Imperial College London, South Kensington Campus, Exhibition Road, London, SW7 2AZ, UK. jtrzebin@imperial.ac.uk
Lab on a Chip
|December 2, 2011
Summary
This study presents a new microfluidic platform for evaluating 3D microspike biosensors. The developed glucose and lactate biosensors show robust performance and reliable enzyme kinetics for clinical applications.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Biosensor Technology
Background:
- Biosensors are crucial for monitoring biological analytes like glucose and lactate.
- Existing biosensor platforms often face limitations in sensitivity, linear range, and real-time analysis.
- 3D microspike array architectures offer potential for enhanced biosensor performance.
Purpose of the Study:
- To develop and characterize a novel microfluidic platform for investigating 3D out-of-plane microspike array biosensors.
- To evaluate the performance of glucose and lactate biosensors fabricated on this platform.
- To elucidate the factors influencing sensor response, such as enzyme kinetics and membrane permeability.
Main Methods:
- Fabrication of 3D microspike arrays bonded to glass slides.
- Modification of microspikes with glucose oxidase or lactate oxidase via covalent coupling.
- Integration of an epoxy-polyurethane membrane to extend the linear working range.
- Utilizing a microfluidic system for real-time performance evaluation and substrate transfer studies.
Main Results:
- Both glucose and lactate biosensors demonstrated effective performance within the clinically relevant substrate concentration range (0-25 mM).
- Microfluidic analysis indicated that sensor response is primarily governed by enzyme kinetics, not membrane permeability.
- The biosensors exhibited consistent and robust performance for over 48 hours.
Conclusions:
- The novel microfluidic platform enables effective investigation of 3D microspike biosensor performance.
- The developed glucose and lactate biosensors are suitable for clinical applications due to their extended linear range and robustness.
- Understanding the dominance of enzyme kinetics is critical for future biosensor design and optimization.

